Read the Latest News

Funding Opportunities now available for the NIH Common Fund’s Acute to Chronic Pain Signatures program

The NIH Common Fund's Acute to Chronic Pain Signatures program aims to understand the biological characteristics underlying the transition from acute to chronic pain and what makes some people susceptible and others resilient to the development of chronic pain.

Opportunity to Voice Your Opinion: U.S. Government Officials Want To Hear from Patients with Pain

FDA Public Meeting on Patient-Focused Drug Development for Chronic Pain On July 9, 2018, FDA hosted a public meeting on Patient-Focused Drug Development for Chronic Pain. https://www.federalregister.gov/documents/2018/05/15/2018-10284/patient-focused-

Consider Including the TMJA in Your Financial Planning

We were recently contacted by Tom P. who informed us that he was including The TMJ Association (TMJA), in his financial planning. Tom wrote the following for us to share with our readers:

The Scoop on TMD Pharmaceuticals

Let's say the National Institutes of Health just handed us a multi-million dollar grant to get to the bottom of TMD and find a cure once and for all. I mean, we could start handing out heating pads left and right, but that kind of relief can only get us so far. Whenever I try a different form of therapy or medication, I like to think about the biology, right down to the cellular and molecular level. Why are the cells that make up my jaw region being such jerks?

Join Us AT TMJ Cafe

The TMJ Association is pleased to partner with Inspire to bring you the TMJ Cafe, a free online support network and discussion community for those with Temporomandibular Disorders (TMD). We invite you to meet others like you, share experiences and tips for getting through the day, and give and receive support.

Funding Opportunities now available for the NIH Common Fund’s Acute to Chronic Pain Signatures program

  • Aug 29, 2018

The NIH Common Fund’s Acute to Chronic Pain Signatures program aims to understand the biological characteristics underlying the transition from acute to chronic pain and what makes some people susceptible and others resilient to the development of chronic pain. A2CPS is part of the NIH-wide HEAL (Helping to End Addiction Long-term) Initiative, an aggressive, trans-NIH effort to speed scientific solutions to stem the national opioid public health crisis. 

Summary:  The A2CPS program will collect data from: (1) patients with acute pain associated with a surgical procedure and (2) patients with acute pain from a musculoskeletal trauma such as a broken bone. Neuroimaging, high-throughput biomedical measurements, sensory testing, and psychosocial assessments collected periodically after the acute pain event will form a comprehensive data set to help predict which patients will develop long-lasting chronic pain. The goal of these studies is to identify individual patient features that together, will provide clinically meaningful, predictive “signatures” of transition or resilience to chronic pain.

The NIH is inviting applications for five funding opportunities: 

Applications are due October 24, 2018.

An informational webinar will be held on September 6th, 2018 from 2-4 PM, EST. 

Join us via WebEx using this link

Call-in toll number (US/Canada): 1-650-479-3208

Event number: 624 155 354

Event password: PainSig

For additional information about the A2CPS program, please visit https://commonfund.nih.gov/pain and contact:

Linda L. Porter, Ph.D.  (RFA-RM-18-033, RFA-RM-18-034, RFA-RM-18-035)

National Institute on Neurological Disorders and Stroke (NINDS)

Telephone: 301-435-7572

Email: porterl@ninds.nih.gov

John Satterlee, Ph.D.  (RFA-RM-18-031, RFA-RM-18-032)

National Institute on Drug Abuse (NIDA)

Telephone: 301-435-1020

Email:  satterleej@nida.nih.gov

The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices.  

The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about the NIH and its programs, visit the NIH website.

TMJ Disorders

Comments:

Login or Register to add Comment

In Treating TMJ

To view or order a free booklet about TMJ Disorders, visit the National Institutes of Health website.

U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
National Institutes of Health
National Institute of Dental and Craniofacial Research
Office of Research on Women's Health